NKG2D expression on HIV-specific CD8+ T cells is reduced in viremic HIV-1-infected patients but maintained in HIV controllers

1INSERM, U1012, Le Kremlin Bicêtre, France 2Institut Pasteur, Unité de Régulation des Infections Rétrovirales, Paris, France 3INSERM U986, Hôpital St-Vincent de Paul, Paris, France 4Université Paris-Sud, U1012, Le Kremlin Bicêtre, France 5AP-HP, Service de Médecine Interne et Maladies Infectieuses, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
JAIDS Journal of Acquired Immune Deficiency Syndromes (Impact Factor: 4.56). 09/2012; 62(1). DOI: 10.1097/QAI.0b013e318274579f
Source: PubMed


NKG2D mediates an important co-stimulatory pathway in CD8 T cells. In HIV infection, we found that NKG2D expression on both total and HIV-specific CD8 T cells was significantly lower in viremic patients than in HIV controllers. Antiretroviral therapy partially restored NKG2D expression on HIV-specific CD8 T cells. We observed a negative correlation between the respective expression levels of CD38 and NKG2D on total CD8 and HIV-specific CD8 T cells. The maintenance of NKG2D expression on CD8 T cells in HIV controllers may contribute to better cell function.

Download full-text


Available from: Asier Sáez-Cirión, Apr 14, 2014
1 Follower
20 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic viral infections can appear in two very different forms: those that are typically immunologically contained after acute symptomatic infection, such as Epstein-Barr virus (EBV), and those that predictably lead to persistent viremia and progressive clinical disease. Human immunodeficiency virus (HIV) infection is typical of the latter and has resulted in more than 20 million deaths worldwide. Here we review a remarkable subset of persons infected with HIV who are able to achieve long-term control of viremia and avoid immunodeficiency without the need for antiviral therapy. We review the contributing role of host genetic factors, innate and adaptive immune responses, and viral factors that may contribute to this phenotype. These individuals indicate that as with other potentially pathogenic chronic viral infections, the human immune system is able to fully control HIV and prevent HIV-associated disease, at least in some individuals. Further understanding of the mechanisms whereby this occurs should yield critical insights for prophylactic and therapeutic antiviral interventions.
    Immunity 10/2007; 27(3):406-16. DOI:10.1016/j.immuni.2007.08.010 · 21.56 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Little is known concerning the stimulatory receptors responsible for tumor cell lysis by NK cells. We generated a monoclonal antibody specific for murine NKG2D in order to investigate its function. Blocking of NKG2D inhibited natural cytotoxicity of all tumor cells tested that express ligands for the receptor. Staining analysis showed that NKG2D is also expressed by activated CD8(+) T cells and macrophages, and subsets of TCRgammadelta(+) and NK1.1(+) T cells. Contradicting reports that NKG2D is solely a costimulatory receptor, we observed that cross-linking of NKG2D directly stimulates NK cells and activated macrophages. In contrast, NKG2D costimulates activated CD8(+) T cells. Thus, NKG2D engagement directly stimulates NK cells and macrophages, costimulates CD8(+) T cells, and plays a substantial role in natural killing.
    Immunity 08/2002; 17(1):19-29. DOI:10.1016/j.immuni.2004.05.003 · 21.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The human MHC class I chain-related genes (MICA and MICB) are located within the HLA class I region of chromosome 6. Their organization, expression and products differ considerably from classical HLA class I genes. MIC proteins are considered to be markers of "stress" in the epithelia, and act as ligands for cells expressing a common activatory natural killer-cell receptor (NKG2D). Molecular models are now available for the MICA protein, both bound and complexed with NKG2D. MICA molecules appear to be highly flexible and polymorphic, although the functional relevance and implications of their polymorphism have yet to be fully discerned.
    Trends in Immunology 08/2001; 22(7):378-85. DOI:10.1016/S1471-4906(01)01960-3 · 10.40 Impact Factor
Show more